Amedeo Smart

Free Medical Literature Service


 

Amedeo

Multiple Sclerosis

  Free Subscription

Articles published in
Can J Neurol Sci
    June 2021
  1. WIJERATNE T, Carroll W
    World Brain Day 2021: Join us to "Stop Multiple Sclerosis": A World Federation of Neurology and Multiple Sclerosis International Federation Collaboration.
    Can J Neurol Sci. 2021 Jun 24:1-2. doi: 10.1017/cjn.2021.
    >> Share

    May 2021
  2. ROBERTS JI, Hahn C, Metz LM
    Multiple sclerosis clinic utilization is associated with fewer emergency department visits.
    Can J Neurol Sci. 2021 May 24:1-14. doi: 10.1017/cjn.2021.
    >> Share

  3. GIACOMINI PS, Oh J, Morrow SA, Beauchemin P, et al
    Videoconferencing and multiple sclerosis management: Stopgap or stay tuned?
    Can J Neurol Sci. 2021 May 17:1-11. doi: 10.1017/cjn.2021.
    >> Share

    January 2021
  4. BALAS M, Popovic MM, Kassardjian CD, Vosoughi R, et al
    Limitation of adduction in a patient with multiple sclerosis related to orbital myositis.
    Can J Neurol Sci. 2021 Jan 28:1-5. doi: 10.1017/cjn.2021.
    >> Share

    July 2020
  5. FREEDMAN MS, Devonshire V, Duquette P, Giacomini PS, et al
    Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.
    Can J Neurol Sci. 2020;47:437-455.
    >> Share

    June 2020
  6. MACLEAN G, Cook P, Lindsay LR, Hatchette TF, et al
    LOW SEROPREVALENCE OF LYME DISEASE AMONG MULTIPLE SCLEROSIS PATIENTS IN NEW BRUNSWICK.
    Can J Neurol Sci. 2020 Jun 29:1-11. doi: 10.1017/cjn.2020.
    >> Share

    May 2020
  7. CHAREST K, Tremblay A, Langlois R, Roger E, et al
    Detecting subtle cognitive impairment in multiple sclerosis with the MoCA test.
    Can J Neurol Sci. 2020 May 26:1-22. doi: 10.1017/cjn.2020.
    >> Share

    April 2020
  8. PARKS NE
    Navigating the TOR of multiple sclerosis.
    Can J Neurol Sci. 2020 Apr 24:1-7. doi: 10.1017/cjn.2020.
    >> Share

  9. SASIKUMAR S, Roy-Hewitson C, Geenen C, Robinson D, et al
    Recurrent Abducens Palsy in Relapsing-Remitting Multiple Sclerosis.
    Can J Neurol Sci. 2020 Apr 7:1-6. doi: 10.1017/cjn.2020.
    >> Share

    December 2019
  10. LYSANDROPOULOS AP, Perrotta G, Billiet T, Ribbens A, et al
    Human Leukocyte Antigen genotype as a marker of Multiple Sclerosis prognosis.
    Can J Neurol Sci. 2019 Dec 2:1-18. doi: 10.1017/cjn.2019.
    >> Share

    October 2019
  11. SADOVNICK AD, Carruthers R, Houtchens M, Schabas A, et al
    Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS): Rationale and Methodology.
    Can J Neurol Sci. 2019 Oct 29:1-6. doi: 10.1017/cjn.2019.
    >> Share

    September 2019
  12. BOSE G, Thebault SDX, Atkins HL, Freedman MS, et al
    Does resetting the immune system fix multiple sclerosis?
    Can J Neurol Sci. 2019 Sep 12:1-35. doi: 10.1017/cjn.2019.
    >> Share

    May 2019
  13. FIANDER MDJ, Bhan V, Stewart SA, Parks NE, et al
    Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab.
    Can J Neurol Sci. 2019 May 22:1-4. doi: 10.1017/cjn.2019.
    >> Share

  14. ATWAL A, Schabas A, Head J, Taylor C, et al
    Laboratory Monitoring Practices Among Canadian Multiple Sclerosis Clinicians.
    Can J Neurol Sci. 2019 May 21:1-5. doi: 10.1017/cjn.2019.
    >> Share

    October 2018
  15. LAPOINTE E, Moghaddam B, Barclay K, Traboulsee AL, et al
    Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis.
    Can J Neurol Sci. 2018 Oct 2:1-3. doi: 10.1017/cjn.2018.
    >> Share

    September 2018
  16. BURTON JM, Traboulsee A
    Nothing Ventured, Nothing Gained? Navigating Disease-Modifying Treatment in Multiple Sclerosis.
    Can J Neurol Sci. 2018;45:487-488.
    >> Share

  17. MIODUSZEWSKI O, MacLean H, Poulin PA, Smith AM, et al
    Trait Mindfulness and Wellness in Multiple Sclerosis.
    Can J Neurol Sci. 2018;45:580-582.
    >> Share

    June 2018
  18. FREEDMAN MS, Selchen D, Prat A, Giacomini PS, et al
    Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing.
    Can J Neurol Sci. 2018 Jun 12:1-15. doi: 10.1017/cjn.2018.
    >> Share

    May 2018
  19. OH J, Gagne-Brosseau MS, Guenette M, Larochelle C, et al
    Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
    Can J Neurol Sci. 2018;45:304-312.
    >> Share

    March 2018
  20. AL-SAKRAN LH, Marrie RA, Blackburn DF, Knox KB, et al
    Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan.
    Can J Neurol Sci. 2018 Mar 20:1-9. doi: 10.1017/cjn.2017.
    >> Share

    December 2017
  21. TURCOTTE LA, Marrie RA, Patten SB, Hirdes JP, et al
    Clinical Profile of Persons with Multiple Sclerosis Across the Continuum of Care.
    Can J Neurol Sci. 2017 Dec 18:1-11. doi: 10.1017/cjn.2017.
    >> Share

    July 2017
  22. BURKHOLDER DB, Koehler PJ, Boes CJ
    Trigeminal Neuralgia and Multiple Sclerosis: A Historical Perspective.
    Can J Neurol Sci. 2017 Jul 19:1-5. doi: 10.1017/cjn.2017.
    >> Share

  23. WALKER LAS, Marino D, Berard JA, Feinstein A, et al
    Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis.
    Can J Neurol Sci. 2017 Jul 7:1-9. doi: 10.1017/cjn.2017.
    >> Share

    May 2017
  24. SADOVNICK AD, Yee IM, Attwell-Pope K, Keyes G, et al
    Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry.
    Can J Neurol Sci. 2017;44:246-254.
    >> Share

    March 2016
  25. LAPIERRE Y, O'Connor P, Devonshire V, Freedman MS, et al
    Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
    Can J Neurol Sci. 2016;43:278-83.
    >> Share

    January 2016
  26. VURAL A, Gocmen R, Kurne AT, Oguz KK, et al
    Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
    Can J Neurol Sci. 2016;43:149-56.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016